review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.ADDR.2005.01.007 |
P698 | PubMed publication ID | 15820557 |
P50 | author | Carolyn Coyne | Q28754337 |
Jeffrey M Bergelson | Q117265334 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 869-882 | |
P577 | publication date | 2005-04-01 | |
P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
P1476 | title | CAR: a virus receptor within the tight junction | |
P478 | volume | 57 |
Q37162704 | A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition |
Q45228579 | A novel chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines |
Q28756756 | A seamless trespass: germ cell migration across the seminiferous epithelium during spermatogenesis |
Q35960465 | Accessibility of the coxsackievirus and adenovirus receptor and its importance in adenovirus gene transduction efficiency |
Q42109130 | Adenoviral vectors for improved gene delivery to the inner ear. |
Q91782423 | Adenovirus Isolated From a Cat Is Related to Human Adenovirus 1 |
Q40213253 | Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells |
Q37848821 | An adenovirus traffic update: from receptor engagement to the nuclear pore |
Q39342777 | Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses |
Q64102673 | Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology |
Q30548627 | CAR regulates epithelial cell junction stability through control of E-cadherin trafficking |
Q50032046 | CAR: A key regulator of adhesion and inflammation |
Q27485899 | CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry |
Q50073229 | Cardiomyocyte-targeted overexpression of the coxsackie-adenovirus receptor causes a cardiomyopathy in association with beta-catenin signaling. |
Q92135537 | Cell junctions and oral health |
Q38110750 | Claudins and other tight junction proteins |
Q26828514 | Claudins: Gatekeepers of lung epithelial function |
Q39892766 | Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells |
Q35029152 | Connections matter--how viruses use cell–cell adhesion components |
Q36171460 | Coxsackie and adenovirus receptor (CAR) is a product of Sertoli and germ cells in rat testes which is localized at the Sertoli-Sertoli and Sertoli-germ cell interface |
Q46247896 | Coxsackie- and adenovirus receptor (CAR) is expressed in lymphatic vessels in human skin and affects lymphatic endothelial cell function in vitro |
Q40540158 | Coxsackievirus Adenovirus Receptor Loss Impairs Adult Neurogenesis, Synapse Content, and Hippocampus Plasticity. |
Q28117555 | Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart |
Q36737010 | Coxsackievirus and adenovirus receptor expression in human endometrial adenocarcinoma: possible clinical implications |
Q64075738 | Data on localization of coxsackievirus and adenovirus receptor (CAR) in prenatal and adult rat olfactory, intestine, pancreas, liver, ovary, and testis |
Q92356999 | Data on localization of coxsackievirus and adenovirus receptor (CAR) in the embryonic rat brain |
Q34781681 | Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. |
Q39714496 | Desmosomes in the testis: Moving into an unchartered territory |
Q93140621 | Differential expression of coxsackievirus and adenovirus receptor in endomyocardial tissue of patients with myocarditis |
Q43915607 | Differential expression of coxsackievirus and adenovirus receptor on alveolar epithelial cells between fetal and adult mice determines their different susceptibility to coxsackievirus B infection |
Q33584186 | Ectoplasmic specialization: a friend or a foe of spermatogenesis? |
Q27485293 | Effect of Cell Polarization on Hepatitis C Virus Entry |
Q39819077 | Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid |
Q36755286 | Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3. |
Q37072417 | Epithelial ICAM-1 and ICAM-2 regulate the egression of human T cells across the bronchial epithelium |
Q37334241 | Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses |
Q30498068 | Expression of coxsackie and adenovirus receptor distinguishes transitional cancer states in therapy-induced cellular senescence |
Q36543945 | Gene transfer into cardiac myocytes. |
Q39447430 | Generation and biological properties of a recombinant dodecahedron containing the short fiber protein of the human adenovirus 41. |
Q90071790 | Generation and evaluation of a chimeric antibody against coxsackievirus and adenovirus receptor for cancer therapy |
Q54215469 | Glycomics and Proteomics Approaches to Investigate Early Adenovirus - Host Cell Interactions. |
Q33879907 | Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis. |
Q36326779 | HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo |
Q42288961 | HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice. |
Q42935421 | Hepatic tight junctions: from viral entry to cancer metastasis |
Q35687541 | Histone deacetylase inhibitors restore cell surface expression of the coxsackie adenovirus receptor and enhance CMV promoter activity in castration-resistant prostate cancer cells |
Q36968335 | Human enterovirus species B in ileocecal Crohn's disease |
Q41844055 | IFITM1 is a tight junction protein that inhibits hepatitis C virus entry |
Q90341968 | Identification of chicken CAR homology as a cellular receptor for the emerging highly pathogenic fowl adenovirus 4 via unique binding mechanism |
Q58616290 | Identification, characterization, expression profiles of OlHavcr2 in medaka (Oryzias latipes) |
Q37774248 | Inadequately treated wastewater as a source of human enteric viruses in the environment |
Q36922434 | Induction of cytopathic effect and cytokines in coxsackievirus B3-infected murine astrocytes |
Q37612896 | Infection kinetics of human adenovirus serotype 41 in HEK 293 cells |
Q38902578 | Inflammation and the Intestinal Barrier: Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair |
Q48139196 | KIF22 coordinates CAR and EGFR dynamics to promote cancer cell proliferation. |
Q54592882 | Ligand-of-Numb protein X is an endocytic scaffold for junctional adhesion molecule 4. |
Q39796306 | Loss of Coxsackie and adenovirus receptor downregulates alpha-catenin expression. |
Q90999822 | Mechanism and therapeutic prospect of resveratrol combined with TRAIL in the treatment of renal cell carcinoma |
Q22252690 | Mechanisms of viral entry: sneaking in the front door |
Q39024327 | Mesenchymal stem cells: a promising tool for targeted gene therapy of endometriosis |
Q34473365 | Modifications of Adenovirus Hexon Allow for Either Hepatocyte Detargeting or Targeting With Potential Evasion From Kupffer Cells |
Q27666534 | Molecular Insights into γδ T Cell Costimulation by an Anti-JAML Antibody |
Q45126624 | Molecular cloning, characterization of porcine IZUMO1, an IgSF family member. |
Q39551866 | Multimerization of adenovirus serotype 3 fiber knob domains is required for efficient binding of virus to desmoglein 2 and subsequent opening of epithelial junctions |
Q33933004 | Multiple phenotypes in adult mice following inactivation of the Coxsackievirus and Adenovirus Receptor (Car) gene |
Q31110179 | Neurotrophin gene therapy for sustained neural preservation after deafness |
Q35140019 | Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini |
Q26776553 | Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications |
Q47095296 | Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope |
Q26787279 | Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis |
Q39607231 | Perspectives on tight junction research |
Q34223177 | Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections. |
Q28270069 | Physiology and function of the tight junction |
Q41619024 | Picornaviruses |
Q38745803 | Polarized rotavirus entry and release from differentiated small intestinal cells |
Q34163593 | Pregnancy loss following coxsackievirus b3 infection in mice during early gestation due to high expression of coxsackievirus-adenovirus receptor (CAR) in uterus and embryo |
Q58792876 | Protective Role of Coxsackie-Adenovirus Receptor in the Pathogenesis of Inflammatory Bowel Diseases |
Q28475714 | Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X |
Q37114578 | Science and technology for water purification in the coming decades. |
Q33559484 | Sertoli-germ cell junctions in the testis: a review of recent data |
Q92376551 | Slow Infection due to Lowering the Amount of Intact versus Empty Particles Is a Characteristic Feature of Coxsackievirus B5 Dictated by the Structural Proteins |
Q39971490 | Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver |
Q36914535 | TNFα promotes CAR-dependent migration of leukocytes across epithelial monolayers. |
Q34981717 | The Coxsackievirus and Adenovirus Receptor (CAR) undergoes ectodomain shedding and regulated intramembrane proteolysis (RIP). |
Q36950916 | The Coxsackievirus and Adenovirus Receptor: Glycosylation and the Extracellular D2 Domain Are Not Required for Coxsackievirus B3 Infection |
Q40774340 | The Intracellular Domain of the Coxsackievirus and Adenovirus Receptor Differentially Influences Adenovirus Entry. |
Q28594893 | The Junctional Adhesion Molecule JAML Is a Costimulatory Receptor for Epithelial γδ T Cell Activation |
Q59353881 | The Role of Oncolytic Viruses in the Treatment of Melanoma |
Q47074232 | The coxsackie and adenovirus receptor (CAR) is required for renal epithelial differentiation within the zebrafish pronephros |
Q40303730 | The coxsackie- and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasis |
Q50067242 | The coxsackie-adenovirus receptor induces an inflammatory cardiomyopathy independent of viral infection |
Q35154333 | The effect of deafness duration on neurotrophin gene therapy for spiral ganglion neuron protection |
Q90575466 | The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models |
Q28482805 | Therapeutic efficacy by targeting correction of Notch1-induced aberrants in uveal tumors |
Q26781335 | Tight Junctions Go Viral! |
Q37733955 | Tight junctions in the testis: new perspectives. |
Q37420725 | Tight junctions: a barrier to the initiation and progression of breast cancer? |
Q36400271 | Tight junctions: molecular architecture and function |
Q34314771 | Toward gene therapy of endometriosis: transductional and transcriptional targeting of adenoviral vectors to endometriosis cells |
Q51846287 | Tumor Restrictions to Oncolytic Virus. |
Q35568762 | Two types of functionally distinct fiber containing structural protein complexes are produced during infection of adenovirus serotype 5 |
Q35757273 | Use of nucleofection to efficiently transfect primary rabbit lacrimal gland acinar cells |
Q40208347 | What is CAR doing in the middle of the adult neurogenic road? |
Search more.